Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Novel Genetic and Phenotypic Expansion in GOSR2-Related Progressive Myoclonus Epilepsy

Hentrich, Lea ; Parnes, Mered ; Lotze, Timothy Edward ; Coorg, Rohini ; de Koning, Tom J LU ; Nguyen, Kha M ; Yip, Calvin K ; Jungbluth, Heinz ; Koy, Anne and Dafsari, Hormos Salimi (2023) In Genes 14(10).
Abstract

Biallelic variants in the Golgi SNAP receptor complex member 2 gene ( GOSR2) have been reported in progressive myoclonus epilepsy with neurodegeneration. Typical clinical features include ataxia and areflexia during early childhood, followed by seizures, scoliosis, dysarthria, and myoclonus. Here, we report two novel patients from unrelated families with a GOSR2-related disorder and novel genetic and clinical findings. The first patient, a male compound heterozygous for the GOSR2 splice site variant c.336+1G>A and the novel c.364G>A,p.Glu122Lys missense variant showed global developmental delay and seizures at the age of 2 years, followed by myoclonus at the age of 8 years with partial response to clonazepam. The second patient,... (More)

Biallelic variants in the Golgi SNAP receptor complex member 2 gene ( GOSR2) have been reported in progressive myoclonus epilepsy with neurodegeneration. Typical clinical features include ataxia and areflexia during early childhood, followed by seizures, scoliosis, dysarthria, and myoclonus. Here, we report two novel patients from unrelated families with a GOSR2-related disorder and novel genetic and clinical findings. The first patient, a male compound heterozygous for the GOSR2 splice site variant c.336+1G>A and the novel c.364G>A,p.Glu122Lys missense variant showed global developmental delay and seizures at the age of 2 years, followed by myoclonus at the age of 8 years with partial response to clonazepam. The second patient, a female homozygous for the GOSR2 founder variant p.Gly144Trp, showed only mild fine motor developmental delay and generalized tonic-clonic seizures triggered by infections during adolescence, with seizure remission on levetiracetam. The associated movement disorder progressed atypically slowly during adolescence compared to its usual speed, from initial intention tremor and myoclonus to ataxia, hyporeflexia, dysmetria, and dystonia. These findings expand the genotype-phenotype spectrum of GOSR2-related disorders and suggest that GOSR2 should be included in the consideration of monogenetic causes of dystonia, global developmental delay, and seizures.

(Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Adolescent, Child, Child, Preschool, Female, Humans, Male, Ataxia/genetics, Dystonia, Dystonic Disorders, Mutation, Myoclonic Epilepsies, Progressive/genetics, Myoclonus, Qb-SNARE Proteins/genetics, Seizures
in
Genes
volume
14
issue
10
article number
1860
publisher
MDPI AG
external identifiers
  • scopus:85175274764
  • pmid:37895210
ISSN
2073-4425
DOI
10.3390/genes14101860
language
English
LU publication?
yes
id
658a6065-21cd-4175-b5f4-a63ef234b401
date added to LUP
2023-11-15 13:46:41
date last changed
2024-04-27 19:51:04
@article{658a6065-21cd-4175-b5f4-a63ef234b401,
  abstract     = {{<p>Biallelic variants in the Golgi SNAP receptor complex member 2 gene ( GOSR2) have been reported in progressive myoclonus epilepsy with neurodegeneration. Typical clinical features include ataxia and areflexia during early childhood, followed by seizures, scoliosis, dysarthria, and myoclonus. Here, we report two novel patients from unrelated families with a  GOSR2-related disorder and novel genetic and clinical findings. The first patient, a male compound heterozygous for the  GOSR2 splice site variant c.336+1G&gt;A and the novel c.364G&gt;A,p.Glu122Lys missense variant showed global developmental delay and seizures at the age of 2 years, followed by myoclonus at the age of 8 years with partial response to clonazepam. The second patient, a female homozygous for the GOSR2 founder variant p.Gly144Trp, showed only mild fine motor developmental delay and generalized tonic-clonic seizures triggered by infections during adolescence, with seizure remission on levetiracetam. The associated movement disorder progressed atypically slowly during adolescence compared to its usual speed, from initial intention tremor and myoclonus to ataxia, hyporeflexia, dysmetria, and dystonia. These findings expand the genotype-phenotype spectrum of GOSR2-related disorders and suggest that  GOSR2 should be included in the consideration of monogenetic causes of dystonia, global developmental delay, and seizures. </p>}},
  author       = {{Hentrich, Lea and Parnes, Mered and Lotze, Timothy Edward and Coorg, Rohini and de Koning, Tom J and Nguyen, Kha M and Yip, Calvin K and Jungbluth, Heinz and Koy, Anne and Dafsari, Hormos Salimi}},
  issn         = {{2073-4425}},
  keywords     = {{Adolescent; Child; Child, Preschool; Female; Humans; Male; Ataxia/genetics; Dystonia; Dystonic Disorders; Mutation; Myoclonic Epilepsies, Progressive/genetics; Myoclonus; Qb-SNARE Proteins/genetics; Seizures}},
  language     = {{eng}},
  month        = {{09}},
  number       = {{10}},
  publisher    = {{MDPI AG}},
  series       = {{Genes}},
  title        = {{Novel Genetic and Phenotypic Expansion in GOSR2-Related Progressive Myoclonus Epilepsy}},
  url          = {{http://dx.doi.org/10.3390/genes14101860}},
  doi          = {{10.3390/genes14101860}},
  volume       = {{14}},
  year         = {{2023}},
}